Galavant Therapeutics, Inc. — Form D

Galavant Therapeutics, Inc. of MENLO PARK, CA, a company, filed a Form D exempt-offering notice with the SEC on 2020-04-01. The offering totals $100K, of which $100K was reported sold. Industry: Biotechnology.

Offering

• Filed: 2020-04-01
• Form: D
• Accession: 0001808255-20-000001
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $100K
• Amount sold: $100K
• Investors: 1
• Date of first sale: 2020-03-20
• Security types: debt
• Revenue range: Decline to Disclose
• SEC file number: 021-364151

Issuer

• Name: Galavant Therapeutics, Inc.
• CIK: 0001808255
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2020
• Address: 155 JEFFERSON DRIVE, SUITE 100, MENLO PARK, CA, 94025
• Phone: 650-268-4252

Officers, directors & promoters (3)

More

• CIK 1808255 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search